The reduction of AP-induced abdominal hyperalgesia by the treatment with HEVm may be a consequence of the decrease of pancreatic inflammatory mediators, such as TNF-α, IL-1β, and IL-6. This evidence concerns the gene TNF and alkaline phosphatase measurement.